RVTY

#730
Revvity, Inc. Common Stock
104.5 2 USD
+2.09%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
103.50
105.04
Range Annuel
81.22
118.26
Changement quotidien
+2.09%
Changement Mensuel
+25.95%
Evolution sur 6 mois
+1.88%
Changement Annuel
+10.18%
Clôture Précédente
102.3 8
Open
103.5 4
Low
103.5 0
High
105.0 4
Volume
1 766
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Revvity, Inc. Common Stock

Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines. In 2022, a split of PerkinElmer resulted in one part, comprising its applied, food and enterprise services businesses, being sold to the private equity firm New Mountain Capital for $2.45 billion and thus no longer being public but keeping the PerkinElmer name. The other part, comprising the life sciences and diagnostics businesses, remained public but required a new name, which in 2023 was announced as Revvity, Inc. From the perspective of Revvity, the goal of creating a separate company was that its businesses might show greater profit margins and more in the way of growth potential. An associated goal was to have more financial flexibility moving forward. On May 16, 2023, the PerkinElmer stock symbol PKI was replaced by the new symbol RVTY.

Nouvelles